4//SEC Filing
COTTRELL SANDRA 4
Accession 0001474064-11-000053
CIK 0000890465other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:04 PM ET
Size
6.1 KB
Accession
0001474064-11-000053
Insider Transaction Report
Form 4
SANDRA COTTRELL
VP, Reg. Affairs & Drug Safety
Transactions
- Award
Stock Options
2011-11-07+8,000→ 8,000 totalExercise: $3.34Exp: 2020-02-19→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On November 7, 2011, the performance criteria for 8,000 of these options had been satisfied because the Issuer's Phase 3 pivotal study of NPSP558 had met the primary efficacy endpoint of a 50 percent or greater reduction in oral calcium supplementation and active vitamin D therapy and a total serum calcium concentration that was normalized or maintained compared to baseline after 24 weeks of treatment. These 8,000 options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeother
Related Parties
1- filerCIK 0001461361
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:04 PM ET
- Size
- 6.1 KB